{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T09:30:37Z","timestamp":1750411837570},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,29]]},"DOI":"10.7759\/cureus.36870","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T17:45:44Z","timestamp":1680111944000},"source":"Crossref","is-referenced-by-count":4,"title":["Atorvastatin Improves the Propionic Acid-Induced Autism in Rats: The Roles of Sphingosine-1-Phosphate and Anti-inflammatory Action"],"prefix":"10.7759","author":[{"given":"Ferit","family":"Duranku\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Korkut","family":"Budak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakup","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim  H","family":"Sever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahattin","family":"\u00d6zkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yigit","family":"Uyan\u0131kgil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oytun","family":"Erbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2021.10.010","article-title":"Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder","volume":"106","author":"Lotufo Denucci B","year":"2021","unstructured":"Lotufo Denucci B, Silva de Lima L, Ferreira Lima Mota I, et al.. Current knowledge, challenges, new perspectives of the study, and treatments of Autism Spectrum Disorder. Reprod Toxicol. 2021, 106:82-93. 10.1016\/j.reprotox.2021.10.010","journal-title":"Reprod Toxicol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136622","article-title":"Therapeutic effect of finasteride through its antiandrogenic and antioxidant role in a propionic acid-induced autism model: demonstrated by behavioral tests, histological findings and MR spectroscopy","volume":"779","author":"Sever IH","year":"2022","unstructured":"Sever IH, Ozkul B, Bozkurt MF, Erbas O. Therapeutic effect of finasteride through its antiandrogenic and antioxidant role in a propionic acid-induced autism model: demonstrated by behavioral tests, histological findings and MR spectroscopy. Neurosci Lett. 2022, 779:136622. 10.1016\/j.neulet.2022.136622","journal-title":"Neurosci Lett"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2010.07.007","article-title":"Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms","volume":"1801","author":"Al-Lahham SH","year":"2010","unstructured":"Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta. 2010, 1801:1175-83. 10.1016\/j.bbalip.2010.07.007","journal-title":"Biochim Biophys Acta"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-74","article-title":"Etiology of autistic features: the persisting neurotoxic effects of propionic acid","volume":"9","author":"El-Ansary AK","year":"2012","unstructured":"El-Ansary AK, Ben Bacha A, Kotb M. Etiology of autistic features: the persisting neurotoxic effects of propionic acid. J Neuroinflammation. 2012, 9:74. 10.1186\/1742-2094-9-74","journal-title":"J Neuroinflammation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087072","article-title":"Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner","volume":"9","author":"Foley KA","year":"2014","unstructured":"Foley KA, Ossenkopp KP, Kavaliers M, Macfabe DF. Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner. PLoS One. 2014, 9:e87072. 10.1371\/journal.pone.0087072","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/life11121365","article-title":"Update on statin treatment in patients with neuropsychiatric disorders","volume":"11","author":"Avan R","year":"2021","unstructured":"Avan R, Sahebnasagh A, Hashemi J, et al.. Update on statin treatment in patients with neuropsychiatric disorders. Life (Basel). 2021, 11:1365. 10.3390\/life11121365","journal-title":"Life (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2017.0055","article-title":"Simvastatin as an adjunctive therapy to risperidone in treatment of autism: a randomized, double-blind, placebo-controlled clinical trial","volume":"28","author":"Moazen-Zadeh E","year":"2018","unstructured":"Moazen-Zadeh E, Shirzad F, Karkhaneh-Yousefi MA, Khezri R, Mohammadi MR, Akhondzadeh S. Simvastatin as an adjunctive therapy to risperidone in treatment of autism: a randomized, double-blind, placebo-controlled clinical trial. J Child Adolesc Psychopharmacol. 2018, 28:82-9. 10.1089\/cap.2017.0055","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0190-z","article-title":"Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)","volume":"9","author":"Stivaros S","year":"2018","unstructured":"Stivaros S, Garg S, Tziraki M, et al.. Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA). Mol Autism. 2018, 9:12. 10.1186\/s13229-018-0190-z","journal-title":"Mol Autism"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi JW","year":"2011","unstructured":"Choi JW, Gardell SE, Herr DR, et al.. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A. 2011, 108:751-6. 10.1073\/pnas.1014154108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1871527320666210806165430","article-title":"Valproic acid and propionic acid modulated mechanical pathways associated with Autism Spectrum Disorder at prenatal and neonatal exposure","volume":"21","author":"Sharma AR","year":"2022","unstructured":"Sharma AR, Batra G, Saini L, et al.. Valproic acid and propionic acid modulated mechanical pathways associated with Autism Spectrum Disorder at prenatal and neonatal exposure. CNS Neurol Disord Drug Targets. 2022, 21:399-408. 10.2174\/1871527320666210806165430","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jdn.10221","article-title":"Granulocyte colony-stimulating factor has a sex-dependent positive effect in the maternal immune activation-induced autism model","volume":"82","author":"Duranku\u015f F","year":"2022","unstructured":"Duranku\u015f F, Albayrak Y, Erdo\u011fan F, Albayrak N, Erdo\u011fan MA, Erba\u015f O. Granulocyte colony-stimulating factor has a sex-dependent positive effect in the maternal immune activation-induced autism model. Int J Dev Neurosci. 2022, 82:716-26. 10.1002\/jdn.10221","journal-title":"Int J Dev Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoimmune disease: from protein prenylation to immunomodulation","volume":"6","author":"Greenwood J","year":"2006","unstructured":"Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006, 6:358-70. 10.1038\/nri1839","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-016-9706-5","article-title":"Atorvastatin modulates regulatory T cells and attenuates cerebral damage in a model of transient middle cerebral artery occlusion in rats","volume":"12","author":"Rodr\u00edguez-Perea AL","year":"2017","unstructured":"Rodr\u00edguez-Perea AL, Gutierrez-Vargas J, Cardona-G\u00f3mez GP, Guarin CJ, Rojas M, Hern\u00e1ndez PA. Atorvastatin modulates regulatory T cells and attenuates cerebral damage in a model of transient middle cerebral artery occlusion in rats. J Neuroimmune Pharmacol. 2017, 12:152-62. 10.1007\/s11481-016-9706-5","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.155","article-title":"QTL replication and targeted association highlight the nerve growth factor gene for nonverbal communication deficits in autism spectrum disorders","volume":"18","author":"Lu AT","year":"2013","unstructured":"Lu AT, Yoon J, Geschwind DH, Cantor RM. QTL replication and targeted association highlight the nerve growth factor gene for nonverbal communication deficits in autism spectrum disorders. Mol Psychiatry. 2013, 18:226-35. 10.1038\/mp.2011.155","journal-title":"Mol Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2017.11.023","article-title":"Neuroprotective effect of an Nrf2-ARE activator identified from a chemical library on dopaminergic neurons","volume":"818","author":"Izumi Y","year":"2018","unstructured":"Izumi Y, Kataoka H, Inose Y, Akaike A, Koyama Y, Kume T. Neuroprotective effect of an Nrf2-ARE activator identified from a chemical library on dopaminergic neurons. Eur J Pharmacol. 2018, 818:470-9. 10.1016\/j.ejphar.2017.11.023","journal-title":"Eur J Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2013.08.006","article-title":"Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells","volume":"1","author":"Steele ML","year":"2013","unstructured":"Steele ML, Fuller S, Patel M, Kersaitis C, Ooi L, M\u00fcnch G. Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox Biol. 2013, 1:441-5. 10.1016\/j.redox.2013.08.006","journal-title":"Redox Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-2-9","article-title":"Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer's disease pathogenesis","volume":"2","author":"Couttas TA","year":"2014","unstructured":"Couttas TA, Kain N, Daniels B, et al.. Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer's disease pathogenesis. Acta Neuropathol Commun. 2014, 2:9. 10.1186\/2051-5960-2-9","journal-title":"Acta Neuropathol Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01465-06","article-title":"Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons","volume":"27","author":"Kajimoto T","year":"2007","unstructured":"Kajimoto T, Okada T, Yu H, Goparaju SK, Jahangeer S, Nakamura S. Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons. Mol Cell Biol. 2007, 27:3429-40. 10.1128\/MCB.01465-06","journal-title":"Mol Cell Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.10.021","article-title":"Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus","volume":"171","author":"Kanno T","year":"2010","unstructured":"Kanno T, Nishizaki T, Proia RL, Kajimoto T, Jahangeer S, Okada T, Nakamura S. Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus. Neuroscience. 2010, 171:973-80. 10.1016\/j.neuroscience.2010.10.021","journal-title":"Neuroscience"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093079","article-title":"Fingolimod modulates dendritic architecture in a BDNF-dependent manner","volume":"21","author":"Patnaik A","year":"2020","unstructured":"Patnaik A, Spiombi E, Frasca A, Landsberger N, Zagrebelsky M, Korte M. Fingolimod modulates dendritic architecture in a BDNF-dependent manner. Int J Mol Sci. 2020, 21:3079. 10.3390\/ijms21093079","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2020.03.041","article-title":"Beneficial effects of Fingolimod on social interaction, CNS and peripheral immune response in the BTBR mouse model of autism","volume":"435","author":"De Simone R","year":"2020","unstructured":"De Simone R, Butera A, Armida M, Pezzola A, Boirivant M, Potenza RL, Ricceri L. Beneficial effects of Fingolimod on social interaction, CNS and peripheral immune response in the BTBR mouse model of autism. Neuroscience. 2020, 435:22-32. 10.1016\/j.neuroscience.2020.03.041","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707114","article-title":"Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins","volume":"150","author":"Igarashi J","year":"2007","unstructured":"Igarashi J, Miyoshi M, Hashimoto T, Kubota Y, Kosaka H. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br J Pharmacol. 2007, 150:470-9. 10.1038\/sj.bjp.0707114","journal-title":"Br J Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/aur.1842","article-title":"Executive function and functional and structural brain differences in middle-age adults with autism spectrum disorder","volume":"10","author":"Braden BB","year":"2017","unstructured":"Braden BB, Smith CJ, Thompson A, et al.. Executive function and functional and structural brain differences in middle-age adults with autism spectrum disorder. Autism Res. 2017, 10:1945-59. 10.1002\/aur.1842","journal-title":"Autism Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-017-0373-0","article-title":"Hippocampus and amygdala radiomic biomarkers for the study of autism spectrum disorder","volume":"18","author":"Chaddad A","year":"2017","unstructured":"Chaddad A, Desrosiers C, Hassan L, Tanougast C. Hippocampus and amygdala radiomic biomarkers for the study of autism spectrum disorder. BMC Neurosci. 2017, 18:52. 10.1186\/s12868-017-0373-0","journal-title":"BMC Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12645","article-title":"Communicating systems in the body: how microbiota and microglia cooperate","volume":"150","author":"Erny D","year":"2017","unstructured":"Erny D, Hrab\u011b de Angelis AL, Prinz M. Communicating systems in the body: how microbiota and microglia cooperate. Immunology. 2017, 150:7-15. 10.1111\/imm.12645","journal-title":"Immunology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg110","article-title":"Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys","volume":"126","author":"Herbert MR","year":"2003","unstructured":"Herbert MR, Ziegler DA, Deutsch CK, et al.. Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain. 2003, 126:1182-92. 10.1093\/brain\/awg110","journal-title":"Brain"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/14734220500208846","article-title":"Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects","volume":"4","author":"Laurence JA","year":"2005","unstructured":"Laurence JA, Fatemi SH. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum. 2005, 4:206-10. 10.1080\/14734220500208846","journal-title":"Cerebellum"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/pd.4942","article-title":"Autism genetics - an overview","volume":"37","author":"Yin J","year":"2017","unstructured":"Yin J, Schaaf CP. Autism genetics - an overview. Prenat Diagn. 2017, 37:14-30. 10.1002\/pd.4942","journal-title":"Prenat Diagn"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-011-1216-y","article-title":"Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder","volume":"42","author":"Corrigan NM","year":"2012","unstructured":"Corrigan NM, Shaw DW, Richards TL, et al.. Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. J Autism Dev Disord. 2012, 42:105-15. 10.1007\/s10803-011-1216-y","journal-title":"J Autism Dev Disord"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.179","article-title":"Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging","volume":"71","author":"Goh S","year":"2014","unstructured":"Goh S, Dong Z, Zhang Y, DiMauro S, Peterson BS. Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. JAMA Psychiatry. 2014, 71:665-71. 10.1001\/jamapsychiatry.2014.179","journal-title":"JAMA Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/136779-atorvastatin-improves-the-propionic-acid-induced-autism-in-rats-the-roles-of-sphingosine-1-phosphate-and-anti-inflammatory-action","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:56Z","timestamp":1707508736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/136779-atorvastatin-improves-the-propionic-acid-induced-autism-in-rats-the-roles-of-sphingosine-1-phosphate-and-anti-inflammatory-action"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.36870","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,29]]}}}